Harbin Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 50.9% in First Half of 2023

Harbin Pharmaceutical Group Co.,Ltd. (哈药集团股份有限公司) (600664.SH) reported a net profit of 221.3 million yuan in the first half of 2023, up 50.9% year-on-year.

Meanwhile, the company posted 7.7 billion yuan in revenue, up 20.1% year-on-year.

At the end of the reporting period, it had 13.7 billion yuan in total assets and 8.6 billion yuan in total liabilities, with a liability-to-asset ratio of 62.3%.